Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.7K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.3K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Comment on 'Context, not class, may be the key signal in systemic JAK inhibitor exposure in MF/SS': reply from authors.

The British journal of dermatology·2026
Same author

Extensive cutaneous viral warts during JAK inhibitor therapy for atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

'What' and 'How' to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Core outcome sets: What are they and why they matter.

The Journal of investigative dermatology·2026
Same author

Mycosis fungoides/Sézary syndrome and systemic Janus kinase inhibitors: a real-world retrospective study on behalf of the EORTC CLTG.

The British journal of dermatology·2026

Related Experiment Video

Updated: Sep 22, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

508

The Eczema Area and Severity Index-A Practical Guide.

Jon M Hanifin1, Wenelia Baghoomian1, Erin Grinich1

  • 1From the Oregon Health & Science University, Portland.

Dermatitis : Contact, Atopic, Occupational, Drug
|May 20, 2022
PubMed
Summary
This summary is machine-generated.

The Eczema Area and Severity Index (EASI) is a validated tool for assessing atopic dermatitis severity. This review provides a definitive guide to EASI use and interpretation for clinicians and researchers.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.3K

Related Experiment Videos

Last Updated: Sep 22, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

508
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.3K

Area of Science:

  • Dermatology
  • Clinical assessment tools

Background:

  • Atopic dermatitis is a prevalent chronic inflammatory skin condition.
  • Accurate assessment of disease extent and severity is crucial for patient management.
  • Existing guides for the Eczema Area and Severity Index (EASI) have limitations.

Purpose of the Study:

  • To provide a definitive guide for the Eczema Area and Severity Index (EASI).
  • To address common questions regarding EASI use and interpretation.
  • To enhance the consistent application of EASI in clinical practice and research.

Main Methods:

  • This is a review article.
  • The review synthesizes existing literature and expert knowledge on the EASI.
  • Commonly asked questions regarding EASI are addressed.

Main Results:

  • The Eczema Area and Severity Index (EASI) is a well-validated instrument for assessing atopic dermatitis.
  • The review clarifies specific aspects of EASI application and scoring.
  • Guidance is provided on interpreting EASI results for disease burden and treatment response.

Conclusions:

  • The Eczema Area and Severity Index (EASI) is essential for standardized atopic dermatitis assessment.
  • This review serves as a comprehensive resource for optimal EASI utilization.
  • Clearer understanding of EASI will improve clinical decision-making and research outcomes.